Gene Polymorphism in Tinea Versicolor
NCT04769804 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-04-26
Summary
Blood samples will be taken from cases presenting with recurrent tinea versicolor , after confirmation of diagnosis by wood's light and KOH examination, for the detection of gene polymorphism in IL17 A and IL17 F.
In addition , serum samples from patients and controls will be tested for 25(OH)2 D3
Conditions
- Recurrent Pityriasis Versicolor
Sponsors & Collaborators
-
Kasr El Aini Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-01
- Primary Completion
- 2021-06-01
- Completion
- 2021-11-01
Countries
- Egypt
Study Locations
More Related Trials
-
Methods Validation Assessment for Study of Inflammatory Skin Disease
NCT03796806 ·Status: COMPLETED
-
Prostaglandin F2-alpha (PGF2α) in Vitiligo
NCT03755830 ·Status: UNKNOWN ·Phase: NA
-
Histochemical Study of Vitiligo in Sohag University Hospital Patients
NCT05869942 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Scanoskin for the Assessment of Vitiligo
NCT03133871 ·Status: COMPLETED
-
Melanin Index in Those With Fitzpatrick Skin Phototypes I-VI
NCT01124513 ·Status: COMPLETED ·Phase: NA
-
Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides
NCT05526638 ·Status: UNKNOWN ·Phase: NA
-
A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo
NCT06319781 ·Status: RECRUITING
-
Expression of LC3-I, LC3-II & Beclin 1 in Vitiligo
NCT03371758 ·Status: UNKNOWN ·Phase: NA
-
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
NCT00001164 ·Status: COMPLETED
-
Dermoscopy in Nails
NCT06696612 ·Status: NOT_YET_RECRUITING
-
Insulin Like Growth Factor-1 Against Oxidative Stress in Vitiligo
NCT05812079 ·Status: NOT_YET_RECRUITING
-
The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity
NCT03741738 ·Status: COMPLETED
-
Correlation Between Objective Skin Pigment Measurement and Fitzpatrick Skin Type
NCT06144541 ·Status: RECRUITING
-
Study of Scaling Disorders and Other Inherited Skin Diseases
NCT00001292 ·Status: COMPLETED
-
The Validation of New Photographic Technology for Assessing Skin Lesions
NCT06663241 ·Status: COMPLETED
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
Tissue and Serum Level of NLRP1, NLRP3 and Il-18 in Early Stages of mf Patients
NCT06066554 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of Hypoxia Inducible Factor and Autophagy Related Genes in Patients With Non-Segmental Vitiligo
NCT06410898 ·Status: RECRUITING ·Phase: NA
-
Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles
NCT00005781 ·Status: COMPLETED
-
Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
NCT02471352 ·Status: RECRUITING
-
Serum Irisin Level In Leprosy Patients
NCT06416033 ·Status: COMPLETED
-
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
NCT03976622 ·Status: UNKNOWN
-
Evaluation of Serum Gasdermin D Level As a Potential Biomarker of Disease Activity in Vitiligo Patients
NCT06584643 ·Status: NOT_YET_RECRUITING
-
Sensory Symptoms in Active Vitiligo
NCT05390164 ·Status: UNKNOWN
-
Resident Memory T Cells in Vitiligo
NCT05223738 ·Status: UNKNOWN